If the current buzz is to be believed, we stand at the precipice of a new dawn in healthcare. Let’s put aside the enthusiasm and provide a dose of reality.
Achieving the objective of delivering AI-driven healthcare can be a risky path. Embarking on this pathway with data sets driving diagnosis must be tempered with clinical and analytical governance and oversight. In this post, we discuss:
- The challenges and opportunities of applying AI to precision medicine, which aims to provide personalized and effective healthcare based on data and evidence.
- The need for data quality, clinical governance, and ethical oversight to ensure AI solutions are reliable, safe and beneficial for patients and providers.
- A proposed five-step process for healthcare providers to explore and implement AI solutions in their organizations, involving data analysis, clinical identification, ROI estimation, MVP modelling and pilot testing.
Learn more here and visit dell.com/mgma to access exclusive benefits.